Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie Harrold

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Pharmacoepidemiology and Drug Safety|December 29, 2016
The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insightsJeffrey R Curtis, Lang Chen, Jeffrey D Greenberg, et al.
Annals of the Rheumatic Diseases|August 21, 2024
Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry studySho Fukui, Wolfgang C Winkelmayer, Sara K Tedeschi, et al.
The Permanente Journal|December 24, 2015
Population Variations in Rheumatoid Arthritis Treatment and Outcomes, Northern California, 1998-2009Lisa J Herrinton, Leslie Harrold, Craig Salman, et al.
Annals of the Rheumatic Diseases|February 7, 2025
Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry studySho Fukui, Wolfgang C Winkelmayer, Sara K Tedeschi, et al.
BMC Musculoskeletal Disorders|June 2, 2012
Malignancy validation in a United States registry of rheumatoid arthritis patientsMark C Fisher, Victoria Furer, Marc C Hochberg, et al.
Arthritis Care & Research|June 7, 2014
Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness researchJeffrey R Curtis, Lang Chen, Aseem Bharat, et al.
Plos One|January 24, 2019
Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritisSiri Lillegraven, Jeffrey D Greenberg, George W Reed, et al.
The Annals of Pharmacotherapy|February 16, 2006
Frequency of serum creatinine monitoring during allopurinol therapy in ambulatory patientsMarsha A Raebel, David L McClure, Steven R Simon, et al.
Seminars in Arthritis and Rheumatism|April 10, 2016
Implementation of treat-to-target in rheumatoid arthritis through a Learning Collaborative: Rationale and design of the TRACTION trialDaniel H Solomon, Sara B Lee, Agnes Zak, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Pharmacoepidemiology and Drug Safety|December 29, 2016
The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insightsJeffrey R Curtis, Lang Chen, Jeffrey D Greenberg, et al.
Annals of the Rheumatic Diseases|August 21, 2024
Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry studySho Fukui, Wolfgang C Winkelmayer, Sara K Tedeschi, et al.
The Permanente Journal|December 24, 2015
Population Variations in Rheumatoid Arthritis Treatment and Outcomes, Northern California, 1998-2009Lisa J Herrinton, Leslie Harrold, Craig Salman, et al.
Annals of the Rheumatic Diseases|February 7, 2025
Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry studySho Fukui, Wolfgang C Winkelmayer, Sara K Tedeschi, et al.
BMC Musculoskeletal Disorders|June 2, 2012
Malignancy validation in a United States registry of rheumatoid arthritis patientsMark C Fisher, Victoria Furer, Marc C Hochberg, et al.
Arthritis Care & Research|June 7, 2014
Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness researchJeffrey R Curtis, Lang Chen, Aseem Bharat, et al.
Plos One|January 24, 2019
Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritisSiri Lillegraven, Jeffrey D Greenberg, George W Reed, et al.
The Annals of Pharmacotherapy|February 16, 2006
Frequency of serum creatinine monitoring during allopurinol therapy in ambulatory patientsMarsha A Raebel, David L McClure, Steven R Simon, et al.
Seminars in Arthritis and Rheumatism|April 10, 2016
Implementation of treat-to-target in rheumatoid arthritis through a Learning Collaborative: Rationale and design of the TRACTION trialDaniel H Solomon, Sara B Lee, Agnes Zak, et al.
Pageof 2